Verekitug Phase Two Details Support Quarterly Asthma Dosing

Evidence Same day detailed data catch-up · Published September 8, 2026 · Discovery September 8, 2026 · Importance 4/5 · Direction Positive Summary Upstream Bio presented full Phase II VALIANT results showing that verekitug 100 mg every 12 weeks reduced annualized severe-asthma exacerbations by 56%…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *